IBM joins in cancer research, diagnosis

Nov 09, 2005

The IBM Corp. announced Tuesday it is joining forces with several research centers to help accelerate cancer research, diagnosis and treatment.

IBM, based in Armonk, N.Y., said it will collaborate with the Memorial Sloan-Kettering Cancer Center, the Molecular Profiling Institute and the CHU Sainte-Justine Research Center under separate agreements.

IBM and Sloan-Kettering will build a state-of-the-art integrated information management system to improve the ability of clinicians and researchers to study long-term cancer-related illnesses, identify disease trends and determine success rates.

"This is an excellent multi-sector model that can drive integration of molecular medicine into areas where it's truly needed, including cancer detection, treatment, and ultimately prevention," said Dr. Anna Barker, deputy director of the National Cancer Institute. "The convergence of advanced technologies and post-genomics science will change cancer medicine in ways we cannot yet envision."

Copyright 2005 by United Press International

Explore further: Apple may deliver ways to rev up the iPad, report says

Related Stories

Recommended for you

Architects to hatch Ecocapsule as low-energy house

17 hours ago

Where people call home depends on varied factors, from poverty level to personal philosophy to vanity to community pressure. Ecocapsule appears to be the result of special factors, a team of architects applying ...

Apple may deliver ways to rev up the iPad, report says

21 hours ago

MacRumors last month said that the latest numbers from market research firm IDC's Worldwide Quarterly Tablet Tracker revealed Apple stayed on as the largest vendor in a declining tablet market. The iPad ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.